Navigation Links
Alfacell Receives Going Concern Audit Opinion
Date:10/23/2008

SOMERSET, N.J., Oct. 23 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that its Annual Report on Form 10-K for the fiscal year ended July 31, 2008, filed with the Securities and Exchange Commission on Oct. 14, 2008, included an audit opinion from its independent registered public accounting firm that expressed doubt about the company's ability to continue as a going concern. The company makes this announcement in compliance with NASDAQ Marketplace Rule 4350(b)(1)(B), which requires that a Nasdaq-listed company that receives an audit opinion in which the auditor expresses doubt about the company's ability to continue as a going concern for a reasonable period of time must make a public announcement through the news media disclosing the receipt of such opinion. This announcement and press release do not represent any amendment to the company's 2008 Annual Report on Form 10-K.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to a recently completed Phase IIIb study in malignant mesothelioma, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit http://www.alfacell.com.

Media and Investor Contact:

David Schull or Wendy Lau

Russo Partners

212-845-4271

David.Schull@russopartnersllc.com

Wendy.Lau@russopartnersllc.com


'/>"/>
SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Alfacell to Present at BIO InvestorForum 2007
2. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
3. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
4. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
5. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
6. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
7. Alfacell Announces Retirement of Chief Executive Officer
8. Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
9. Alfacell Receives NASDAQ Non-Compliance Notification
10. Alfacell Receives NASDAQ Delisting Letter
11. Alfacell Hires Advisors to Advance Strategic Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... PA (PRWEB) , ... April 18, 2017 , ... ... to Halo Labs . The move comes after the company changed focus ... new market, our new brand and our new technology,” says CEO Robert Hart. ...
(Date:4/19/2017)... York, NY (PRWEB) , ... April 19, 2017 ... ... to combat Clostridium difficile (C. diff) infections through education and advocacy. Founded ... her life to a C. diff infection, the foundation has become the most-consulted ...
(Date:4/19/2017)... , April 19, 2017  As a ... Abuse and Heroin Summit ,  Proove® Biosciences, Inc. ... analyzing genetics, environmental, and lifestyle factors to accurately ... the University of Southern California (USC), the Interventional ... and Proove publish results showing that Proove Opioid ...
(Date:4/19/2017)... 19, 2017   Thermo Fisher Scientific Inc ... Procalcitonin MOnitoring SEpsis (MOSES) Study have been published ... Critical Care Medicine . Researchers from the study, ... Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis ... PCT (procalcitonin) assay to assess risk for 28 ...
Breaking Biology Technology:
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):